Could your own cells tame type 1 diabetes? new study tests safety
NCT ID NCT05207995
First seen Nov 01, 2025 · Last updated May 23, 2026 · Updated 30 times
Summary
This early-phase study tested whether a new cell therapy is safe for people with type 1 diabetes. Researchers took immune cells from 32 participants, turned them into 'tolerogenic dendritic cells' in a lab, and gave them back to the patients. The goal was to see if these cells could calm the immune attack on the pancreas without causing serious side effects, potentially helping to control the disease long-term.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETES MELLITUS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Healthcare institution "Minsk City Clinical Endocrinology Center"
Minsk, 220000, Belarus
Conditions
Explore the condition pages connected to this study.